Ionizable Lipid Purification Using Scavenger Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying ionizable lipids, such as ionizable amino lipids (IALs), are inefficient and costly, particularly due to the reliance on column chromatography, which increases production time and solvent usage, and do not effectively remove impurities that form adducts with mRNA, affecting the stability and efficacy of lipid nanoparticles (LNPs).
Innovation Solution
A method involving scavenging-removal processes using specific scavengers to react with reactive impurities like alkyl halides and aldehydes, followed by acid extraction and neutralization, allows for the separation of impurities through liquid-liquid extraction without column chromatography, resulting in high-purity IALs suitable for LNPs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If column chromatography is used for purifying ionizable lipids, then purification effectiveness is improved, but production time and solvent usage increase
Solution Approach 1:
The patent changes the chemical parameters of the purification system by introducing specific scavengers (such as thiols, phosphines, or amines) that selectively react with impurities like alkyl halides and aldehydes. This chemical transformation converts the purification approach from physical adsorption (chromatography) to chemical reaction-based removal, achieving high purity without column chromatography and thereby reducing production time and solvent usage.
Solution Approach 2:
The patent extracts and removes specific impurities (alkyl halides, aldehydes) from the ionizable lipid composition by using scavengers that selectively bind to these impurities. The scavenger-impurity complexes are then separated from the desired product through liquid-liquid extraction or filtration, achieving effective purification without the need for time-consuming column chromatography.
2Manufacturing precision
If column chromatography is used for purifying ionizable lipids, then purification effectiveness is improved, but cost and environmental impact increase
Solution Approach 1:
The patent transforms the purification mechanism from solvent-dependent physical separation (chromatography) to chemical reaction-based removal. By using scavengers that chemically react with impurities to form easily separable complexes, the method achieves effective purification with minimal solvent usage and without the environmental burden of large volumes of chromatography solvents.
Solution Approach 2:
The patent selectively extracts impurities through chemical reaction with scavengers, followed by simple separation methods. This approach removes harmful substances (alkyl halides, aldehydes) effectively while avoiding the excessive solvent consumption associated with column chromatography, thereby reducing both cost and environmental impact.
3Manufacturing precision
If conventional purification methods are used, then impurities are removed, but adduct-forming impurities remain that affect mRNA stability and efficacy
Solution Approach 1:
The patent applies preliminary anti-action by using scavengers to preemptively react with and neutralize impurities (alkyl halides, aldehydes) before they can form harmful adducts with mRNA. This preventive chemical treatment ensures that impurities are eliminated at the purification stage, guaranteeing mRNA stability and efficacy in the final LNP product.
Solution Approach 2:
The patent converts harmful impurities into beneficial or harmless substances through chemical reaction with scavengers. The impurities (alkyl halides, aldehydes) that would otherwise form detrimental adducts with mRNA are transformed into scavenger-impurity complexes that are easily removed, thereby protecting mRNA integrity and ensuring product reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high purity of ionizable lipids by reducing or eliminating impurities, thereby enhancing the stability and efficacy of mRNA-based vaccines and therapies by minimizing adduct formation, without the need for column chromatography, thus reducing costs and environmental impact.
Implementation Method 1
contacting the first composition with a first scavenger, wherein the first scavenger reacts with the first reactive impurity to form a first scavenger-impurity product
Implementation Method 2
contacting the second composition with an acid, wherein the acid reacts with the IAL to form an IAL salt that is soluble in a polar solvent
Implementation Method 3
converting the IAL salt into the IAL with a neutralizing agent
Implementation Method 4
separating the IAL from the second scavenger-impurity product, or a derivative thereof formed by the neutralizing agent, by transferring the IAL into the second nonpolar solvent
Data Source
AI summary
Provided herein are methods for purifying an ionizable amino lipid (IAL) composition comprising impurities that may react with polynucleotides, such as mRNA. Methods for purifying IAL compositions comprise one or more scavenging-removal steps to selectively remove reactive impurities.